Dental Caries Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Dental Caries Global Clinical Trials Review, H1, 2013" provides data on the Dental Caries clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dental Caries. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dental Caries. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Dental Caries 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Dental Caries 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Dental Caries Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Oragenics, Inc. 33
Clinical Trial Overview of Oragenics, Inc. 33
GC Corporation 34
Clinical Trial Overview of GC Corporation 34
Nanova, Inc 35
Clinical Trial Overview of Nanova, Inc 35
CHX Technologies Inc. 36
Clinical Trial Overview of CHX Technologies Inc. 36
GABA GmbH 37
Clinical Trial Overview of GABA GmbH 37
GC EUROPE N.V. 38
Clinical Trial Overview of GC EUROPE N.V. 38
GABA International AG 39
Clinical Trial Overview of GABA International AG 39
Queensland Health 40
Clinical Trial Overview of Queensland Health 40
3M ESPE AG 41
Clinical Trial Overview of 3M ESPE AG 41
Air Liquide Sante International 42
Clinical Trial Overview of Air Liquide Sante International 42
Indiana Nanotech, LLC 43
Clinical Trial Overview of Indiana Nanotech, LLC 43
Cargill 44
Clinical Trial Overview of Cargill 44
Riemser Arzneimittel AG 45
Clinical Trial Overview of Riemser Arzneimittel AG 45
Clinical Trial Overview of Top Universities / Institutes / Hospitals 46
The University of Hong Kong 46
Clinical Trial Overview of The University of Hong Kong 46
Hadassah Medical Organization 47
Clinical Trial Overview of Hadassah Medical Organization 47
University of Washington 48
Clinical Trial Overview of University of Washington 48
University of California, San Francisco 49
Clinical Trial Overview of University of California, San Francisco 49
University of Sao Paulo 50
Clinical Trial Overview of University of Sao Paulo 50
University of Copenhagen 51
Clinical Trial Overview of University of Copenhagen 51
University of Glasgow 52
Clinical Trial Overview of University of Glasgow 52
University of Otago 53
Clinical Trial Overview of University of Otago 53
Shiraz University of Medical Sciences 54
Clinical Trial Overview of Shiraz University of Medical Sciences 54
Islamic Azad University, Tehran 55
Clinical Trial Overview of Islamic Azad University, Tehran 55
Universita degli Studi di Sassari 56
Clinical Trial Overview of Universita degli Studi di Sassari 56
Assistance Publique - Hopitaux de Paris 57
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 57
University of Turku 58
Clinical Trial Overview of University of Turku 58
The University of North Carolina 59
Clinical Trial Overview of The University of North Carolina 59
University of Campinas, Brazil 60
Clinical Trial Overview of University of Campinas, Brazil 60
Temple University 61
Clinical Trial Overview of Temple University 61
The University of Melbourne 62
Clinical Trial Overview of The University of Melbourne 62
Mahidol University 63
Clinical Trial Overview of Mahidol University 63
Louisiana State University 64
Clinical Trial Overview of Louisiana State University 64
Mashhad University of Medical Sciences 65
Clinical Trial Overview of Mashhad University of Medical Sciences 65
China Pharmaceutical Guidebook Series (3) 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products